On 29 Sept, uniQure announced additional data from its ongoing phase 1/2 studies, comparing updated 36-month and 48-month outcomes with propensity score-matched external controls: uniqure.gcs-web.com/news-release...
#HuntingtonsDisease #ClinicalResearch
On 29 Sept, uniQure announced additional data from its ongoing phase 1/2 studies, comparing updated 36-month and 48-month outcomes with propensity score-matched external controls: uniqure.gcs-web.com/news-release...
#HuntingtonsDisease #ClinicalResearch
#HuntingtonsDisease
#HuntingtonsDisease
#EnrollHD
#HuntingtonsDisease
#EnrollHD
#HuntingtonsDisease
Regular EHDN members can vote for the Executive Committee and Scientific & Bioethics Advisory Committee until 19 October 2026.
👉 VOTE NOW! Your vote helps shape the future of EHDN.
Results will be announced at the EHDN Clinical Research Congress in Kraków.
Regular EHDN members can vote for the Executive Committee and Scientific & Bioethics Advisory Committee until 19 October 2026.
👉 VOTE NOW! Your vote helps shape the future of EHDN.
Results will be announced at the EHDN Clinical Research Congress in Kraków.
📅 29 Sept, 16:00–17:30 CEST 📍 Zoom
Further information & registration link to follow - stay tuned
📅 29 Sept, 16:00–17:30 CEST 📍 Zoom
Further information & registration link to follow - stay tuned
Supports early-career HD clinicians/researchers with a 6-week placement at a leading multidisciplinary HD clinic in Europe.
Further information: ehdn.org/hd-clinician...
Questions? ✉️ fellowship@ehdn.org
#HuntingtonsDisease
Supports early-career HD clinicians/researchers with a 6-week placement at a leading multidisciplinary HD clinic in Europe.
Further information: ehdn.org/hd-clinician...
Questions? ✉️ fellowship@ehdn.org
#HuntingtonsDisease
📅 29 Sept, 16:00–17:30 CEST 📍 Zoom
Further information & registration link to follow - stay tuned
📅 29 Sept, 16:00–17:30 CEST 📍 Zoom
Further information & registration link to follow - stay tuned
Applications open 1 Sept! Supports early-career HD clinicians/researchers with a 6-week placement at a leading multidisciplinary HD clinic in Europe.
Further information: ehdn.org/hd-clinician...
Questions? ✉️ fellowship@ehdn.org
#HuntingtonsDisease #Training
Applications open 1 Sept! Supports early-career HD clinicians/researchers with a 6-week placement at a leading multidisciplinary HD clinic in Europe.
Further information: ehdn.org/hd-clinician...
Questions? ✉️ fellowship@ehdn.org
#HuntingtonsDisease #Training
Applications open 1 Sept! Supports early-career HD clinicians/researchers with a 6-week placement at a leading multidisciplinary HD clinic in Europe.
Further information: ehdn.org/hd-clinician...
Questions? ✉️ fellowship@ehdn.org
#HuntingtonsDisease #Training
Applications open 1 Sept! Supports early-career HD clinicians/researchers with a 6-week placement at a leading multidisciplinary HD clinic in Europe.
Further information: ehdn.org/hd-clinician...
Questions? ✉️ fellowship@ehdn.org
#HuntingtonsDisease #Training
Register here: na.eventscloud.com/ereg/index.p...
#HuntingtonsDisease #HDCommunity #Advocacy #ClinicalResearch
Register here: na.eventscloud.com/ereg/index.p...
#HuntingtonsDisease #HDCommunity #Advocacy #ClinicalResearch
Register here: na.eventscloud.com/ereg/index.p...
#HuntingtonsDisease #HDCommunity #Advocacy #ClinicalResearch
Register here: na.eventscloud.com/ereg/index.p...
#HuntingtonsDisease #HDCommunity #Advocacy #ClinicalResearch
22–24 Oct 2026, Kraków
🧬 Treatment pipeline: biomarkers to access
📋 Trial updates & regulatory perspectives
🔬 Latest scientific advances
🗣️ Community perspectives
Register: na.eventscloud.com/ereg/index.p...
#HuntingtonsDisease
22–24 Oct 2026, Kraków
🧬 Treatment pipeline: biomarkers to access
📋 Trial updates & regulatory perspectives
🔬 Latest scientific advances
🗣️ Community perspectives
Register: na.eventscloud.com/ereg/index.p...
#HuntingtonsDisease
More than a stamp of approval – it's a recognised quality marker for HD clinical studies, strengthening research through expert review before it reaches participants.
📰 Read more: ehdn.org/wp-content/u...
#HuntingtonsDisease #ClinicalResearch
More than a stamp of approval – it's a recognised quality marker for HD clinical studies, strengthening research through expert review before it reaches participants.
📰 Read more: ehdn.org/wp-content/u...
#HuntingtonsDisease #ClinicalResearch
More than a stamp of approval – it's a recognised quality marker for HD clinical studies, strengthening research through expert review before it reaches participants.
📰 Read more: ehdn.org/wp-content/u...
#HuntingtonsDisease #ClinicalResearch #DrugDevelopment
More than a stamp of approval – it's a recognised quality marker for HD clinical studies, strengthening research through expert review before it reaches participants.
📰 Read more: ehdn.org/wp-content/u...
#HuntingtonsDisease #ClinicalResearch #DrugDevelopment
Your vote shapes how EHDN drives Huntington's disease research, trials & care.
Vote: ehdn.genolive.de/index.php?pa...
#HuntingtonsDisease #EHDN
Your vote shapes how EHDN drives Huntington's disease research, trials & care.
Vote: ehdn.genolive.de/index.php?pa...
#HuntingtonsDisease #EHDN
📖 Read her story in the latest EHDN News: ehdn.org/wp-content/u...
#HuntingtonsDisease #RareDisease
📖 Read her story in the latest EHDN News: ehdn.org/wp-content/u...
#HuntingtonsDisease #RareDisease
📖 Read her story in the latest EHDN News: ehdn.org/wp-content/u...
#HuntingtonsDisease #RareDisease
📖 Read her story in the latest EHDN News: ehdn.org/wp-content/u...
#HuntingtonsDisease #RareDisease
All welcome - people with HD, families, researchers, industry & more.
More info: ehdn.org/ehdn-heated-...
Congress: ehdn.org/ehdn2026/
Registration closes 31 July!
#HuntingtonsDisease
All welcome - people with HD, families, researchers, industry & more.
More info: ehdn.org/ehdn-heated-...
Congress: ehdn.org/ehdn2026/
Registration closes 31 July!
#HuntingtonsDisease
Jenny Townhill (EHDN & Cardiff University) presented on current clinical trials in Huntington's disease at the East Midlands HD Network event in Leicester, 11 July. The network is led by Sarah Gunn, Flaviano Giorgini & Reza Kiani (University of Leicester)
Jenny Townhill (EHDN & Cardiff University) presented on current clinical trials in Huntington's disease at the East Midlands HD Network event in Leicester, 11 July. The network is led by Sarah Gunn, Flaviano Giorgini & Reza Kiani (University of Leicester)